Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients

NCT06901297 is registered in ClinicalTrials.gov with Materia Medica Holding as lead sponsor.

NCT NCT06901297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06901297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Clinical Trial of the Efficacy and Safety of Raphamin in the Treatment of Acute Rhinosinusitis in Adult Patients
Lead sponsor
Materia Medica Holding
Phase
Phase 3
Overall status
Recruiting
Start date
April 3, 2025
Completion date
December 31, 2027
Enrollment
552 (estimated)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

rhinosinusitis, rhinosinusitis acute